Navigation Links
MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
Date:1/31/2008

VANCOUVER and SAN DIEGO, Jan. 31 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, will add a 600mg celgosivir combination therapy arm to its currently enrolling Phase II viral kinetics study in hepatitis C virus ("HCV") treatment-naive patients. The protocol amendment to this study has received Health Canada and Institutional Review Board (IRB) approvals. The purpose of this new treatment arm is to assess 600mg celgosivir (an oral alpha glucosidase I inhibitor) for tolerability, pharmacokinetics and viral kinetics when combined with the standard of care drugs, pegylated interferon plus ribavirin, as compared to the standard of care drugs alone and to 400mg celgosivir plus the standard of care for up to 12 weeks of therapy.

AnnKatrin Petersen, M.D., VP Clinical Development for MIGENIX commented, "The favorable tolerability experienced to date with 400mg per day of celgosivir in triple combination with pegylated interferon plus ribavirin, along with the clinically significant benefit demonstrated in our previous non-responder study, gives us confidence that increasing the dose to 600mg per day in combination therapy is an important development step for the optimization and advancement of celgosivir."

The currently enrolling Phase II viral kinetics study is a 12-week randomized, active-controlled study initially planned to enroll up to 20 patients in two treatment arms: (i) celgosivir (400mg once daily) plus peginterferon alfa-2b plus ribavirin ("PRC"); and (ii) peginterferon alfa-2b plus ribavirin ("PR"). Tolerability, pharmacokinetics and viral kinetics are being evaluated in the trial. The approved protocol amendment allows for the addition of a 600mg once daily dosing arm and the flexibility to increase the total number of patients in the study up to 50. With 15 patients enrolled to date, it is planned that approximately six additional patients will be enrolled, all in th
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
2. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
3. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
5. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
6. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
7. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
8. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
9. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
10. Phase 1 Studies Show Promise of QuatRxs Novel Compound, Sobetirome, for Lowering LDL Cholesterol Levels
11. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008).../ -- BioTrends Research Group, Inc.,released its 1...cation, a,syndicated report offering comprehensive...one and mineral metabolism in Chronic Kidney Disea...tion from 182 US,Nephrologists -- data were collec..., In the renal anemia market, while the use of ES...
(Date:7/25/2008)...rstCall/ -- Caraco Pharmaceutical,Laboratories, Lt...arter of,Fiscal 2009, ended June 30, 2008, of $108...orresponding period of Fiscal 2008. This represent...scal 2008. Pre-tax income grew,to $14.6 million fo...a,pre-tax income of $9.6 million during the corres...
(Date:7/25/2008)...ain Hearing in Both Ears for the First ...25 /- Cochlear, the world,s leader in...landmark milestone when,Dr. Thomas Roland, Jr., MD...0th cochlear implant device procedure. Today, 72-y...dergo surgery to receive bilateral (a,device in ea...
(Date:7/25/2008)...survey on creativity, sponsored by the Jerusalem-b...Teleseker, revealed that a majority of the Israeli...special methods that could "put them into a c...ong as desired." , J... survey on creativity, sponsored by the Jerusalem-...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 2Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 3Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 4Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3
...evel protein expression within a variety,of cell...agene , Recombinant adenoviruses provide a versa...escribe the AdEasy adenoviral vector,system, ... viruses. Constructing a recombinant adenoviral,...ss in which the desired,expression cassette is f...
...r RT-PCR using the Absolutely RNA , ...ter Jeff Braman , Stratagene , S...ation kits are , not satisfactory for rev... tested several commercially available RNA ...ontaminating DNA will produce false positive ampli...
...ful method to detect protein interactions in mamma...Stratagene , With Stratagenes mammalian two-hybr...protein-protein interactions via the activation,...s as a result of,reconstitution of a functional ...,two hybrid proteins. It allows researchers to st...
...ferentiated Adipocytes ,,, A new para...i C. Halvorsen ,Zen-Bio, Inc. , Peter Pingerel... , Ligand Pharmaceuticals , Michael R. Briggs ...ne introduces new tools to facilitate the study of...d Adipocytes and Human Differentiated Adipocytes.,...
Other Biology Technology:Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 2Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 3Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 4Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 5Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 6New Kit Generates Exceptionally Pure Total RNA for RT-PCR 2New Kit Generates Exceptionally Pure Total RNA for RT-PCR 3New Kit Generates Exceptionally Pure Total RNA for RT-PCR 4New Kit Generates Exceptionally Pure Total RNA for RT-PCR 5New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 2New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 3New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 4New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 5New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 6New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 7New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 8New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 9Human Primary Preadipocytes and Differentiated Adipocytes 2Human Primary Preadipocytes and Differentiated Adipocytes 3Human Primary Preadipocytes and Differentiated Adipocytes 4Human Primary Preadipocytes and Differentiated Adipocytes 5Human Primary Preadipocytes and Differentiated Adipocytes 6
(Date:7/24/2008)... Stanford, CASteroids bulk up plants just as they...signals that tell the genes to boost growth and de...han in human and animal cells. A new study by plan...merging molecular approach called proteomics to id...nderstanding how these plant hormones activate gen...
(Date:7/24/2008)... Glasses embedded with a telescope promise to mak...ve and do other activities requiring sharper dista...ists describe the advantages of these innovative g...d in the May/June issue of Journal of Biomedical ... month. , "This new design has several advantag...
(Date:7/24/2008)... July 24, 2008 A new study by researchers from C...th addresses one of the most challenging issues in...transmission in poor countries. In these settings...he best outcome for their infants, they should exc...four to six months after birth. But according to t...
(Date:7/24/2008)... Researchers at The Pennsylvania State University...iscovered that the efficacy of imiquimod, a clinic...t antiviral and antitumor activity, is dependent o...r) axis for its action. This discovery, reported ...d Medicine , provides new insights into a widely u...
Breaking Biology News(10 mins):Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 1Clarient Names Michael J Pellini M D Chief Operating Officer 2845 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 4Safety Tips for a Fun and Spooky Halloween 2843 1Safety Tips for a Fun and Spooky Halloween 2843 2Prime Therapeutics Announces URAC Accreditation 2840 1Prime Therapeutics Announces URAC Accreditation 2840 2National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 1National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 2National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 3National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 4
...e thought to be essential in helping chemotherapy ...In a new study of chemo patients, scientists at th...Cancer Institute found that 70 percent of subjects...till alive after five years. Patients with normal ... findings raise the possibility of a new strategy ...
...it comes to growing cells in a lab, technique matt... cells grown in three-dimensional cultures use 1,7... in standard two-dimensional petri dishes. , , T...ineering, adds to a growing body of research showi...t cell growth and function. This research shows th...
...te hundreds of families being told their children ...dren may be able to eat peanuts safely, a study by...(UNSW) and Sydney Children,s Hospital has found. ,...ording to the Australasian Society of Clinical Imm...ant finding," said Dr Brynn Wainstein, a Sydney Ch...
...eport, published in the prestigious international ...aecology, found that the rise could not be explain... such as complications in pregnancy or labour/deli..., The research project looked at all births in Wes...0,000 births) and analysed the mode of delivery....
Other Biology News:Gene thought to assist chemo may help cancer thrive 2Gene thought to assist chemo may help cancer thrive 3Growing nerve cells in 3-D dramatically affects gene expression 2Peanut allergies overstated, study finds 2Study shows dramatic increase in Caesarean sections 2
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds
...y RNA Spikes for the normalization and control of ...ng and for protocol assessment and optimization. C...ybridization stringency and background. Normalize ...Spots, and complementary RNA Spikes for the normal...
Kit for Detection of Mitochondrial Membrane Potential
Biology Products: